COMMUNIQUÉS West-GlobeNewswire

Aviragen and Vaxart Amend Terms of Merger Agreement to Increase the Value for Aviragen Stockholders

07/02/2018 - 21:22

ATLANTA and SOUTH SAN FRANCISCO, Calif., Feb. 07, 2018 (GLOBE NEWSWIRE) -- Aviragen Therapeutics, Inc. (NASDAQ: AVIR ) and Vaxart, Inc. today announced that the companies have agreed to amend the terms of their [...]

Adamas to Present at the LEERINK Partners 7th Annual Global Healthcare Conference

07/02/2018 - 20:09

EMERYVILLE, Calif., Feb. 07, 2018 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS ) today announced that Gregory T. Went, Ph.D., Founder, Chairman and Chief Executive Officer of Adamas, is scheduled to [...]

Rutgers New Jersey Medical School Selects Alpha Clinical Systems ACS360 eSource Platform for Clinical Trial Data Capture

07/02/2018 - 19:53

PISCATAWAY, N.J., Feb. 07, 2018 (GLOBE NEWSWIRE) -- Alpha Clinical Systems, the leading provider of affordable and comprehensive next-generation eSource solutions, today announced that Rutgers New Jersey Medical School [...]

Corizon Health Names New CFO

07/02/2018 - 19:21

BRENTWOOD, Tenn., Feb. 07, 2018 (GLOBE NEWSWIRE) -- To help meet Corizon Health’s goal of redefining the nation’s standard of excellence for correctional healthcare, CEO Steve Rector today announced Shalin Shah has [...]

News Release: Changes to Essilor International (Compagnie Générale d'Optique) Board of Directors

07/02/2018 - 18:01

Changes to Essilor International (Compagnie Générale d'Optique) Board of Directors PDF Version of the news release Charenton-le-Pont, France (February 7, 2018 - 6:00 p.m.) - The Board of Directors of Essilor [...]

Communiqué : Evolution de la composition du Conseil d'administration d'Essilor International (Compagnie Générale d'Optique)

07/02/2018 - 18:01

Evolution de la composition du Conseil d'administration d'Essilor International (Compagnie Générale d'Optique) Version PDF du communiqué Charenton-le-Pont, France (le 7 février 2018 - 18h00) - Le Conseil d' [...]

Voyager Therapeutics to Present at Leerink Partners Annual Global Healthcare Conference

07/02/2018 - 17:00

CAMBRIDGE, Mass., Feb. 07, 2018 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (NASDAQ: VYGR ), a clinical-stage gene therapy company developing life-changing treatments for severe neurological diseases, today announced [...]

Innovate Biopharmaceuticals to Highlight Progress in Celiac Disease and NASH at BIO CEO & Investor Conference on Monday, February 12, 2018 at 3:30PM ET

07/02/2018 - 16:30

RALEIGH, N.C., Feb. 07, 2018 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals, Inc. (Nasdaq: INNT ) a clinical stage biotechnology company focused on developing novel autoimmune and inflammation therapeutics, announced [...]

Orphan’s Court of City of Jurmala Has Appointed Older Daughter of Valerijs Maligins to be the Guardian of His Inheritance

07/02/2018 - 16:18

Olaine, 2018-02-07 16:18 CET (GLOBE NEWSWIRE) -- Orphan’s court of the City of Jurmala, after assessing the application of Irina Maligina has appointed her the guardian of inheritance of Valerijs Maligins, the verdict [...]

Amended News Release - Aspri Pharma Canada Inc. Announces Acquisition of Subordinate Voting Shares of Devonian Health Group Inc.

07/02/2018 - 15:57

CONCORD, Ontario, Feb. 07, 2018 (GLOBE NEWSWIRE) -- Aspri Pharma Canada Inc. (“ Aspri ), a pharmaceutical products wholesale and manufacturer corporation, announces that on February 1, 2018, Devonian Health Group Inc [...]

Tyme Provides Clinical and Corporate Update for Fiscal Third Quarter 2017

07/02/2018 - 15:44

NEW YORK, Feb. 07, 2018 (GLOBE NEWSWIRE) -- Tyme Technologies, Inc. (NASDAQ: TYME ), a clinical-stage biotechnology company developing cancer therapeutics, today announced a clinical and corporate update for the fiscal [...]

Auris Medical Reports New Data Highlighting Superior Bioavailability of AM-125 Compared to Oral Betahistine

07/02/2018 - 15:11

Single dose animal study demonstrates 5 to 35 times higher bioavailability of intranasal betahistine relative to oral betahistine Bioavailability of intranasal betahistine in humans estimated to be 20 to 40 times higher [...]

Actinium Pharmaceuticals Reminds Investors of Record Date for Rights Offering

07/02/2018 - 15:00

- Record date established as February 14, 2018 - To be a shareholder of record, investors are advised to own Actinium stock by 4:00 PM ET, Monday, February 12, 2018 to account for T+2 settlement timing - Actinium’s [...]

Abeona Therapeutics Reports on Initial Safety and Biopotency Signals in MPS IIIB Gene Therapy Clinical Trial

07/02/2018 - 14:45

First-in-man AAV9-based gene therapy delivered by single intravenous injection targeting central nervous system and peripheral manifestations of MPS IIIB. ABO-101 is well tolerated and demonstrates early biopotency [...]

Advanced Proteome Therapeutics and ImmunoBiochem Corporation enter into a Collaboration and Option Agreement

07/02/2018 - 14:30

VANCOUVER, British Columbia and TORONTO, Feb. 07, 2018 (GLOBE NEWSWIRE) -- Advanced Proteome Therapeutics Corporation (APC), a therapeutics discovery and development company, and ImmunoBiochem Corporation, today [...]

BriaCell to Attend 20th Annual BIO CEO & Investor Conference

07/02/2018 - 14:30

BERKELEY, Calif. and VANCOUVER, British Columbia, Feb. 07, 2018 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. ("BriaCell") (TSX-V: BCT ) (OTCQB:BCTXF), an immuno-oncology focused biotechnology company with a [...]

EyeGate to Present at the 2018 BIO CEO & Investor Conference

07/02/2018 - 14:30

WALTHAM, Mass., Feb. 07, 2018 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG ) (“EyeGate” or the “Company”), a clinical-stage, specialty pharmaceutical company with two proprietary platform technologies [...]

Dyadic International, Inc. Announces Research and Development Collaboration To Produce An Active Ingredient in C1

07/02/2018 - 14:30

JUPITER, Fla., Feb. 07, 2018 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”) (OTCQX:DYAI), a global biotechnology company focused on further improving and applying its proprietary C1 gene expression platform [...]

Cellectar Receives USPTO Notice of Allowance for Patent Covering Use of CLR 131 in Multiple Myeloma

07/02/2018 - 14:15

MADISON, Wis., Feb. 07, 2018 (GLOBE NEWSWIRE) -- Cellectar Biosciences (Nasdaq: CLRB ), a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment [...]